title: Treatment of pediatric anxiety disorders.
abstract: This article provides a brief review of the current available data concerning present treatment and potential new treatment advances for pediatric anxiety disorders, such as generalized anxiety disorder, separation anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. Disorder-specific treatment methods and innovations, particularly computer-assisted methods of delivery for cognitive behavioral therapy (CBT) will be reviewed. Additionally, the paper will discuss novel psychopharmacological compounds (e.g., D-cycloserine, riluzole, memantine, and anticonvulsant medications). Available evidence for the efficacy of novel medication strategies in adult studies and implications for their use in pediatrics will be discussed.
authors.affiliation: New York State Psychiatric Institute, New York, New York.
authors.forename: Amy
authors.initials: A
authors.lastname: Rapp
authors.forename: Alice
authors.initials: A
authors.lastname: Dodds
authors.forename: John T
authors.initials: JT
authors.lastname: Walkup
authors.forename: Moira
authors.initials: M
authors.lastname: Rynn
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000523:psychology / Q000628:therapy*; D001010:Anxiety, Separation / Q000523:psychology / Q000628:therapy; D002648:Child; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003523:Cycloserine / Q000627:therapeutic use; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000523:psychology / Q000628:therapy; D010698:Phobic Disorders / Q000523:psychology / Q000628:therapy; D019782:Riluzole / Q000627:therapeutic use; D013313:Stress Disorders, Post-Traumatic / Q000523:psychology / Q000628:therapy
chemical_list: D000927:Anticonvulsants; D019782:Riluzole; D003523:Cycloserine
keywords: anxiety; cognitive behavioral therapy; pediatric; pharmacotherapy